AISAP is an AI-powered point-of-care ultrasound (POCUS) platform founded in 2021 by Adiel Am-Shalom, a former officer in Israel's 8200 intelligence unit, alongside a group of cardiologists including Professor Robert Klempfner; the company is based in Tel Aviv and has raised about $13 million in seed funding from investors including Harel Insurance and Shoni Health Ventures.
The software interprets cardiac ultrasound images at the bedside in real time, flagging structural heart disease and cardiac dysfunction and generating structured reports the company says cut documentation time by up to 90%. It works with existing ultrasound devices plus a hospital's PACS and EMR systems rather than requiring dedicated hardware, and its CARDIO product became the first in the CADx pathway to win FDA clearance for comprehensive structural heart disease diagnosis via POCUS.
AISAP is built for hospitals, urgent care centers, and cardiology clinics, including research partners like Stanford, Mayo Clinic, and Massachusetts General Hospital, that want expert-level cardiac reads at the point of care rather than waiting on a remote specialist. Pricing is customized per institution and available only by requesting a demo, with no published rate card.
